Last update 29 Jun 2024

Cilostazol/ginkgo-biloba

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Renexin, SID 142, SID-142
Target
Mechanism
PDE3 inhibitors(Phosphodiesterase 3 inhibitors)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
KR (29 Oct 2009),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC20H27N5O2
InChIKeyRRGUKTPIGVIEKM-UHFFFAOYSA-N
CAS Registry73963-72-1

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Myocardial Infarction
KR
29 Oct 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peripheral Arterial DiseasePhase 3
KR
20 Feb 2017
Vestibular NeuronitisPhase 3
KR
01 Jul 2013
Arterial Occlusive DiseasesPhase 1-01 Jun 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
344
atsprbjvij(nsytoemgbp) = the incidence of adverse reactions was significantly lower in the SID142 group (22.35% vs 39.29%; P = 0.0171) uxbyujtpbe (xzmbeygmou )
Positive
08 Apr 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free